Antitumor Efficacy of Lymphokine-activated Killer Cells and Recombinant Interleukin 2 in Vivo: Successful Immunotherapy of Established Pulmonary Metastases from Weakly Immunogenic and Nonimmunogenic Murine Tumors of Three Distinct Histological Types

Moshe Z. Papa, James J. Mulé, Steven A. Rosenberg

Research output: Contribution to journal › Article › peer-review

153 Scopus citations

Fingerprint

Dive into the research topics of 'Antitumor Efficacy of Lymphokine-activated Killer Cells and Recombinant Interleukin 2 in Vivo: Successful Immunotherapy of Established Pulmonary Metastases from Weakly Immunogenic and Nonimmunogenic Murine Tumors of Three Distinct Histological Types'. Together they form a unique fingerprint.

Medicine & Life Sciences